Blood Reagent Price-Fixing MDL Survives Dismissal Bid

Law360, New York (August 25, 2010, 1:14 PM EDT) -- Immucor Inc. and Johnson & Johnson subsidiary Ortho-Clinical Diagnostics Inc. have lost bids to scrap multidistrict litigation in which a consolidated putative class of hospitals, blood banks and medical labs has accused the companies of conspiring to fix prices for blood reagents in the United States.

In a memorandum and order issued Monday in the U.S. District Court for the Eastern District of Pennsylvania, Judge Jan Dubois denied the defendants’ motion to dismiss the plaintiffs’ consolidated amended complaint, saying Immucor and Ortho-Clinical failed to show that...
To view the full article, register now.